FDA Approved: GENOTROPIN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental application for Genotropin (somatropin) from Pfizer Laboratories Div Pfizer Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease with Growth Failure
• Growth Hormone Deficiency
• Idiopathic Short Stature
• Noonan Syndrome
• Prader-willi Syndrome
• Small For Gestational Age with Growth Failure
• Turner Syndrome

Drugs mentioned

• GENOTROPIN (SOMATROPIN)

Snippet

SUPPL AP for GENOTROPIN (SOMATROPIN)